MT-ND5 Antibody

What is MT-ND5 and what is its biological significance?

MT-ND5 (Mitochondrially Encoded NADH Dehydrogenase 5) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). This protein plays a crucial role in electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. MT-ND5 is essential for both the catalytic activity and assembly of Complex I . Expression of MT-ND5 occurs ubiquitously in tissues with high energy demands such as the heart, brain, and skeletal muscle where efficient ATP production is essential . As a mitochondrially encoded protein, MT-ND5 is particularly important in research focused on mitochondrial genetics, bioenergetics, and disorders associated with mitochondrial dysfunction.

What applications are MT-ND5 antibodies validated for?

MT-ND5 antibodies have been validated for multiple experimental applications, with varying degrees of optimization across techniques:

Most commercially available MT-ND5 antibodies are primarily optimized for Western blotting and immunohistochemistry applications . Researchers should carefully review validation data for their specific application of interest before proceeding.

What species reactivity can be expected from MT-ND5 antibodies?

Due to the relatively high conservation of mitochondrial proteins across species, many MT-ND5 antibodies show cross-reactivity with multiple organisms:

The majority of commercial antibodies are validated against human, mouse, and rat MT-ND5 . When planning experiments with other species, researchers should perform sequence alignment analysis to predict potential cross-reactivity and conduct preliminary validation studies before proceeding with full-scale experiments.

How can I validate the specificity of an MT-ND5 antibody?

Thorough validation of MT-ND5 antibodies is essential due to the hydrophobic nature and mitochondrial localization of this protein. Recommended validation approaches include:

• Biochemical validation:

  • Confirm expected molecular weight (~67 kDa) in Western blot

  • Perform peptide competition assays using the immunizing peptide

  • Compare results with alternative antibodies targeting different MT-ND5 epitopes

  • Verify mitochondrial enrichment in subcellular fractionation studies

• Genetic validation approaches:

  • Test antibody in cells with known MT-ND5 mutations

  • Compare staining in tissues with variable MT-ND5 expression levels

  • If possible, utilize cells with MT-ND5 depletion (though challenging due to its mitochondrial DNA encoding)

• Imaging validation:

  • Confirm co-localization with established mitochondrial markers

  • Verify absence of signal in non-mitochondrial compartments

  • Assess signal reduction following treatments affecting mitochondrial integrity or abundance

A robust validation strategy should incorporate multiple complementary approaches to establish antibody specificity with high confidence.

What are optimal sample preparation conditions for MT-ND5 immunoblotting?

Successful detection of MT-ND5 by Western blotting requires specialized sample preparation:

• Extraction protocol:

  • Isolate mitochondrial fraction from cells/tissues to enrich target protein

  • Use extraction buffers containing appropriate detergents (1-2% digitonin or 1% DDM)

  • Include protease inhibitor cocktails to prevent degradation

  • Maintain cold temperatures throughout sample processing

• Gel electrophoresis considerations:

  • Utilize 10-12% polyacrylamide gels for optimal separation

  • Consider gradient gels (4-15%) for improved resolution

  • Run at lower voltage (80-100V) to prevent sample overheating

  • Transfer to PVDF membranes (preferable over nitrocellulose for hydrophobic proteins)

• Detection optimization:

  • Block membranes with 5% non-fat milk or BSA in TBST

  • Incubate with primary antibody (typically 1:500-1:1000) overnight at 4°C

  • Use extended washing steps (6 × 5 minutes) to reduce background

  • Expected molecular weight: approximately 67 kDa

Following this protocol typically yields specific detection of MT-ND5 with minimal background or non-specific bands.

How should I approach troubleshooting weak or absent MT-ND5 signal?

When experiencing difficulties detecting MT-ND5, consider these systematic troubleshooting approaches:

• Sample-related issues:

  • Verify mitochondrial integrity in your preparation

  • Assess protein degradation with general mitochondrial markers

  • Confirm protein loading is sufficient (MT-ND5 may be less abundant than other mitochondrial proteins)

  • Test fresh sample preparation without freeze-thaw cycles

• Antibody-related troubleshooting:

  • Titrate antibody concentration (try 2-3× higher concentration)

  • Extend primary antibody incubation time (up to 48-72 hours at 4°C)

  • Validate antibody using positive control tissue (heart or brain tissue is recommended)

  • Test alternative antibodies targeting different epitopes of MT-ND5

• Protocol modifications:

  • Try different membrane types (PVDF often superior to nitrocellulose)

  • Implement signal enhancement systems (HRP polymer detection or amplification reagents)

  • Adjust detergent type and concentration in extraction buffer

  • Consider specialized extraction methods for hydrophobic membrane proteins

Systematic evaluation of these factors will help identify the source of detection problems and guide appropriate protocol modifications.

How can MT-ND5 antibodies be used to study mitochondrial dysfunction in disease models?

MT-ND5 antibodies provide valuable tools for investigating mitochondrial dysfunction in various pathological conditions through multiple methodological approaches:

• Tissue-specific expression analysis:

  • Immunohistochemistry to assess MT-ND5 levels in affected tissues

  • Comparison between diseased and healthy control samples

  • Co-localization studies with cell type-specific markers

• Complex I deficiency assessment:

  • Western blot quantification of MT-ND5 levels relative to other mitochondrial proteins

  • Correlation with enzymatic activity measurements

  • Evaluation of MT-ND5:porin ratio as an indicator of complex I abundance

• Mutation impact studies:

  • Analysis of MT-ND5 stability in cells harboring mtDNA mutations

  • Assessment of complex I assembly in disease models

  • Monitoring MT-ND5 degradation rates in affected tissues

These approaches can provide insights into the molecular mechanisms underlying diseases associated with mitochondrial dysfunction, including neurodegenerative disorders, metabolic diseases, and aging-related conditions.

What are optimal conditions for MT-ND5 immunohistochemistry?

Effective MT-ND5 immunohistochemistry requires careful attention to tissue processing and staining conditions:

• Fixation and processing:

  • 4% paraformaldehyde fixation (12-24 hours) preserves mitochondrial structure

  • Cryosectioning often provides better epitope preservation than paraffin embedding

  • For FFPE tissues, heat-mediated antigen retrieval in citrate buffer (pH 6.0) is essential

• Staining protocol optimization:

  • Extended blocking (1-2 hours) with 5-10% normal serum matching secondary antibody host

  • Primary antibody dilution typically 1:100-1:200 for most commercial antibodies

  • Extended primary antibody incubation (overnight to 48 hours at 4°C)

  • Tyramide signal amplification can enhance detection sensitivity

• Controls and validation:

  • Include no-primary antibody controls to assess background

  • Use tissues with known high MT-ND5 expression (heart, brain) as positive controls

  • Compare staining pattern with other mitochondrial markers

These conditions should be optimized for each specific antibody and tissue type to ensure reliable and reproducible results.

How can MT-ND5 antibodies be used in dual immunofluorescence experiments?

Dual immunofluorescence using MT-ND5 antibodies requires careful planning and optimization:

• Antibody selection and compatibility:

  • Choose primary antibodies raised in different host species when possible

  • If using same-species antibodies, consider sequential staining protocols

  • Verify that both antibodies perform optimally under the same fixation conditions

• Staining protocol:

  • Fix cells/tissues in 4% paraformaldehyde for 15-20 minutes

  • Permeabilize with 0.2% Triton X-100 for 10 minutes

  • Block with 5% normal serum, 1% BSA for 1 hour

  • Apply primary antibodies simultaneously (if from different species) or sequentially

  • Use fluorophore-conjugated secondary antibodies with minimal spectral overlap

  • Include DAPI or other nuclear counterstain for orientation

• Imaging considerations:

  • Acquire images sequentially to minimize bleed-through

  • Include single-stained controls for setting acquisition parameters

  • Use confocal microscopy for improved co-localization analysis

  • Apply appropriate background subtraction before co-localization quantification

These approaches enable investigation of MT-ND5 relationship with other mitochondrial proteins or cellular structures in normal and pathological conditions.

How should MT-ND5 antibodies be used for quantitative Western blot analysis?

Accurate quantification of MT-ND5 by Western blotting requires methodological rigor:

• Sample preparation standardization:

  • Process all samples simultaneously under identical conditions

  • Prepare multiple technical replicates for each biological sample

  • Quantify protein concentration using reliable methods (BCA or Bradford assay)

  • Load equal amounts of total protein (typically 20-30 μg per lane)

• Loading controls and normalization:

  • Use mitochondrial housekeeping proteins (VDAC/porin, SDHA) rather than cellular housekeeping proteins

  • Consider total protein normalization methods (Ponceau S, REVERT staining)

  • Include calibration standards if absolute quantification is needed

• Quantification approach:

  • Capture images within the linear dynamic range of the detection system

  • Analyze band intensity using appropriate software (ImageJ, Image Lab, etc.)

  • Calculate MT-ND5:loading control ratio for each sample

  • Normalize experimental samples to control condition

• Statistical analysis:

  • Perform experiments with sufficient biological replicates (minimum n=3)

  • Apply appropriate statistical tests based on data distribution

  • Report both statistical significance and effect size

This methodological approach enables reliable quantification of MT-ND5 levels for comparative studies across experimental conditions or disease states.

How can I correlate MT-ND5 protein levels with Complex I activity?

Establishing correlations between MT-ND5 abundance and Complex I function requires parallel analysis of protein levels and enzymatic activity:

• Experimental design:

  • Process samples for both protein analysis and activity measurements

  • Maintain consistent conditions for all samples

  • Include controls with known Complex I deficiency

  • Consider time-course studies to capture dynamic relationships

• Protein quantification:

  • Quantify MT-ND5 by Western blot as described above

  • Consider analyzing multiple Complex I subunits (nuclear and mitochondrially encoded)

  • Normalize to mitochondrial content markers

• Activity measurements:

  • Spectrophotometric NADH:ubiquinone oxidoreductase assay

  • In-gel activity staining following blue native PAGE

  • High-resolution respirometry

  • Normalize activity to mitochondrial content markers

• Correlation analysis:

  • Plot MT-ND5 levels against Complex I activity for each sample

  • Calculate Pearson or Spearman correlation coefficient

  • Evaluate statistical significance of correlation

  • Consider multivariate analysis if examining multiple proteins/activities

This approach can reveal whether MT-ND5 abundance is a limiting factor or reliable biomarker for Complex I function in specific biological contexts.

How can MT-ND5 antibodies be applied in single-cell analysis techniques?

Recent advances enable MT-ND5 detection at the single-cell level:

• Flow cytometry applications:

  • Fixation and permeabilization optimized for mitochondrial proteins

  • Higher antibody concentrations typically required (1:50-1:100)

  • Validation with mitochondrial membrane potential dyes

  • Gating strategies to distinguish high/low MT-ND5 expressing populations

• Mass cytometry (CyTOF):

  • Metal-conjugated MT-ND5 antibodies for multiparameter analysis

  • Compatibility with mitochondrial function indicators

  • Clustering analysis to identify cell populations with distinct mitochondrial profiles

• Single-cell imaging:

  • High-content screening platforms for population analysis

  • Super-resolution microscopy for submitochondrial localization

  • Live-cell compatible antibody fragments for dynamic studies

These single-cell approaches provide insights into cell-to-cell variability in MT-ND5 expression and mitochondrial function that are masked in bulk population analyses.

What considerations are important when using MT-ND5 antibodies in studies of mitochondrial DNA mutations?

Studies involving mtDNA mutations affecting MT-ND5 require specialized approaches:

• Antibody epitope considerations:

  • Verify that antibody epitope is not affected by the specific mutation

  • Consider antibodies targeting different regions of MT-ND5

  • Test antibody performance in samples with known mutations

• Heteroplasmy analysis:

  • Combine immunodetection with genetic quantification of mutation load

  • Consider single-cell techniques to address cellular heterogeneity

  • Correlate protein levels with heteroplasmy percentage

• Functional correlations:

  • Compare protein abundance with assembly status of Complex I

  • Assess relationship between MT-ND5 detection and functional parameters

  • Evaluate compensatory responses in other respiratory chain components

• Controls and validation:

  • Use cybrid cell lines with defined mtDNA backgrounds

  • Include samples with varying heteroplasmy levels

  • Consider longitudinal analysis to track mutation and protein dynamics

These considerations enable meaningful interpretation of MT-ND5 antibody results in the context of mitochondrial genetics research.